NanoString Technologies Inc (NSTGQ)
0.0922
-0.01
(-7.80%)
USD |
OTCM |
May 28, 16:00
NanoString Technologies Cash from Operations (Quarterly): -19.70M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -19.70M |
June 30, 2023 | -31.45M |
March 31, 2023 | -35.75M |
December 31, 2022 | -28.08M |
September 30, 2022 | -37.80M |
June 30, 2022 | -32.47M |
March 31, 2022 | -30.25M |
December 31, 2021 | -17.52M |
September 30, 2021 | -28.86M |
June 30, 2021 | -15.31M |
March 31, 2021 | -28.86M |
December 31, 2020 | -10.88M |
September 30, 2020 | -20.64M |
June 30, 2020 | -22.36M |
March 31, 2020 | -27.78M |
December 31, 2019 | -19.54M |
September 30, 2019 | -20.73M |
June 30, 2019 | -20.98M |
March 31, 2019 | -28.18M |
December 31, 2018 | -14.42M |
September 30, 2018 | -11.33M |
June 30, 2018 | -10.47M |
March 31, 2018 | -17.85M |
December 31, 2017 | -12.35M |
Date | Value |
---|---|
September 30, 2017 | -10.34M |
June 30, 2017 | -13.70M |
March 31, 2017 | -15.27M |
December 31, 2016 | -6.43M |
September 30, 2016 | -3.969M |
June 30, 2016 | -3.261M |
March 31, 2016 | 7.581M |
December 31, 2015 | -4.60M |
September 30, 2015 | -7.497M |
June 30, 2015 | -14.54M |
March 31, 2015 | -16.72M |
December 31, 2014 | -4.879M |
September 30, 2014 | -12.50M |
June 30, 2014 | -7.621M |
March 31, 2014 | -13.06M |
December 31, 2013 | -9.863M |
September 30, 2013 | -7.241M |
June 30, 2013 | -5.232M |
March 31, 2013 | -9.01M |
December 31, 2012 | -3.668M |
September 30, 2012 | -3.98M |
June 30, 2012 | -4.245M |
March 31, 2012 | -2.915M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-37.80M
Minimum
Sep 2022
-10.88M
Maximum
Dec 2020
-24.94M
Average
-25.07M
Median
Cash from Operations (Quarterly) Benchmarks
Bruker Corp | 21.80M |
Azenta Inc | 8.356M |
Harvard Bioscience Inc | 1.403M |
Bionano Genomics Inc | -28.13M |
Akoya Biosciences Inc | -20.82M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -1.916M |
Cash from Financing (Quarterly) | 0.822M |
Free Cash Flow | -135.74M |
Free Cash Flow Per Share (Quarterly) | -0.453 |
Free Cash Flow to Equity (Quarterly) | -22.00M |
Free Cash Flow to Firm (Quarterly) | -21.07M |
Free Cash Flow Yield | -3.12K% |